{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:03:17Z","timestamp":1793660597987,"version":"4.5.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"The Netherlands Organization for Scientific Research","award":["016.158.306"],"award-info":[{"award-number":["016.158.306"]}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2014-StG 639776"],"award-info":[{"award-number":["ERC-2014-StG 639776"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2R44AI058375"],"award-info":[{"award-number":["2R44AI058375"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>We assessed the impact of exposure to Plasmodium falciparum on parasite kinetics, clinical symptoms, and functional immunity after controlled human malaria infection (CHMI) in 2 cohorts with different levels of previous malarial exposure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Nine adult males with high (sero-high) and 10 with low (sero-low) previous exposure received 3200 P. falciparum sporozoites (PfSPZ) of PfSPZ Challenge by direct venous inoculation and were followed for 35 days for parasitemia by thick blood smear (TBS) and quantitative polymerase chain reaction. Endpoints were time to parasitemia, adverse events, and immune responses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ten of 10 (100%) volunteers in the sero-low and 7 of 9 (77.8%) in the sero-high group developed parasitemia detected by TBS in the first 28 days (P = .125). The median time to parasitemia was significantly shorter in the sero-low group than the sero-high group (9 days [interquartile range {IQR} 7.5\u201311.0] vs 11.0 days [IQR 7.5\u201318.0], respectively; log-rank test, P = .005). Antibody recognition of sporozoites was significantly higher in the sero-high (median, 17.93 [IQR 12.95\u201324] arbitrary units [AU]) than the sero-low volunteers (median, 10.54 [IQR, 8.36\u201312.12] AU) (P = .006). Growth inhibitory activity was significantly higher in the sero-high (median, 21.8% [IQR, 8.15%\u201329.65%]) than in the sero-low group (median, 8.3% [IQR, 5.6%\u201310.23%]) (P = .025).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>CHMI was safe and well tolerated in this population. Individuals with serological evidence of higher malaria exposure were able to better control infection and had higher parasite growth inhibitory activity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Trials Registration<\/jats:title><jats:p>NCT03496454.<\/jats:p><\/jats:sec>","DOI":"10.1093\/cid\/ciz740","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T11:13:27Z","timestamp":1564658007000},"page":"2544-2552","source":"Crossref","is-referenced-by-count":42,"title":["Serologic Markers of Previous Malaria Exposure and Functional Antibodies Inhibiting Parasite Growth Are Associated With Parasite Kinetics Following a Plasmodium falciparum Controlled Human Infection"],"prefix":"10.1093","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8111-025X","authenticated-orcid":false,"given":"Jane","family":"Achan","sequence":"first","affiliation":[{"name":"Disease Control and Elimination Theme, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaie J","family":"Reuling","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi Zen","family":"Yap","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgard","family":"Dabira","sequence":"first","affiliation":[{"name":"Disease Control and Elimination Theme, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullahi","family":"Ahmad","sequence":"first","affiliation":[{"name":"Disease Control and Elimination Theme, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momodou","family":"Cox","sequence":"first","affiliation":[{"name":"Disease Control and Elimination Theme, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis","family":"Nwakanma","sequence":"first","affiliation":[{"name":"Disease Control and Elimination Theme, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Tetteh","sequence":"first","affiliation":[{"name":"Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido J H","family":"Bastiaens","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas","family":"Abebe","sequence":"first","affiliation":[{"name":"Sanaria Inc, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Manoj","sequence":"first","affiliation":[{"name":"Sanaria Inc, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harparkash","family":"Kaur","sequence":"first","affiliation":[{"name":"Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoyo","family":"Miura","sequence":"first","affiliation":[{"name":"Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Long","sequence":"first","affiliation":[{"name":"Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F","family":"Billingsley","sequence":"first","affiliation":[{"name":"Sanaria Inc, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B Kim Lee","family":"Sim","sequence":"first","affiliation":[{"name":"Sanaria Inc, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L","family":"Hoffman","sequence":"first","affiliation":[{"name":"Sanaria Inc, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Drakeley","sequence":"first","affiliation":[{"name":"Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2666-094X","authenticated-orcid":false,"given":"Teun","family":"Bousema","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"D\u2019Alessandro","sequence":"first","affiliation":[{"name":"Disease Control and Elimination Theme, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"key":"2020061010550795400_CIT0001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S0031182015001249","article-title":"Immunity to malaria in an era of declining malaria transmission","volume":"143","author":"Fowkes","year":"2016","journal-title":"Parasitology"},{"key":"2020061010550795400_CIT0002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/CMR.00025-08","article-title":"Acquired immunity to malaria","volume":"22","author":"Doolan","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"2020061010550795400_CIT0003","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cid\/cit174","article-title":"An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection","volume":"57","author":"Tran","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2020061010550795400_CIT0004","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1126\/science.3299709","article-title":"Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications","volume":"237","author":"Hoffman","year":"1987","journal-title":"Science"},{"key":"2020061010550795400_CIT0005","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4269\/ajtmh.17-0343","article-title":"Impact of sickle cell trait and naturally acquired immunity on uncomplicated malaria after controlled human malaria infection in adults in Gabon","volume":"98","author":"Lell","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2020061010550795400_CIT0006","volume-title":"World malaria report","author":"World Health Organization","year":"2018"},{"key":"2020061010550795400_CIT0007","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.4269\/ajtmh.13-0250","article-title":"Marked decline in malaria prevalence among pregnant women and their offspring from 1996 to 2010 on the south Kenyan coast","volume":"89","author":"Kalayjian","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"2020061010550795400_CIT0008","doi-asserted-by":"crossref","first-page":"e0128792","DOI":"10.1371\/journal.pone.0128792","article-title":"Changing malaria prevalence on the Kenyan coast since 1974: climate, drugs and vector control","volume":"10","author":"Snow","year":"2015","journal-title":"PLoS One"},{"key":"2020061010550795400_CIT0009","doi-asserted-by":"crossref","first-page":"e1002047","DOI":"10.1371\/journal.pmed.1002047","article-title":"Age, spatial, and temporal variations in hospital admissions with malaria in Kilifi County, Kenya: a 25-year longitudinal observational study","volume":"13","author":"Mogeni","year":"2016","journal-title":"PLoS Med"},{"key":"2020061010550795400_CIT0010","doi-asserted-by":"crossref","first-page":"20142657","DOI":"10.1098\/rspb.2014.2657","article-title":"Gradual acquisition of immunity to severe malaria with increasing exposure","volume":"282","author":"Griffin","year":"2015","journal-title":"Proc Biol Sci"},{"key":"2020061010550795400_CIT0011","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4269\/ajtmh.1993.48.432","article-title":"Human immune responses to the Plasmodium falciparum ring-infected erythrocyte surface antigen (Pf155\/RESA) after a decrease in malaria transmission in Madagascar","volume":"48","author":"Migot","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"2020061010550795400_CIT0012","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1475-2875-13-83","article-title":"Dramatic declines in seropositivity as determined with crude extracts of Plasmodium falciparum schizonts between 2000 and 2010 in Dielmo and Ndiop, Senegal","volume":"13","author":"Diop","year":"2014","journal-title":"Malar J"},{"key":"2020061010550795400_CIT0013","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/1475-2875-13-451","article-title":"Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of western Kenya, 1994-2009","volume":"13","author":"Wong","year":"2014","journal-title":"Malar J"},{"key":"2020061010550795400_CIT0014","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri2902","article-title":"Experimental human challenge infections can accelerate clinical malaria vaccine development","volume":"11","author":"Sauerwein","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"2020061010550795400_CIT0015","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00479-17","article-title":"Controlled human malaria infection: applications, advances, and challenges","volume":"86","author":"Stanisic","year":"2018","journal-title":"Infect Immun"},{"key":"2020061010550795400_CIT0016","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12936-015-0628-0","article-title":"Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres","volume":"14","author":"Mordm\u00fcller","year":"2015","journal-title":"Malar J"},{"key":"2020061010550795400_CIT0017","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12936-015-0817-x","article-title":"Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-na\u00efve volunteers: effect of injection volume and dose on infectivity rates","volume":"14","author":"G\u00f3mez-P\u00e9rez","year":"2015","journal-title":"Malar J"},{"key":"2020061010550795400_CIT0018","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.14-0119","article-title":"Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites","volume":"91","author":"Shekalaghe","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"2020061010550795400_CIT0019","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12936-015-0671-x","article-title":"Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya","volume":"14","author":"Hodgson","year":"2015","journal-title":"Malar J"},{"key":"2020061010550795400_CIT0020","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4269\/ajtmh.17-1014","article-title":"Safety, immunogenicity, and protective efficacy against controlled human malaria infection of Plasmodium falciparum sporozoite vaccine in Tanzanian adults","volume":"99","author":"Jongo","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2020061010550795400_CIT0021","article-title":"Controlled human malaria infection of healthy lifelong malaria-exposed adults to assess safety, immunogenicity and efficacy of the asexual blood stage malaria vaccine candidate GMZ2 [manuscript published online ahead of print 18 December 2018]","author":"Dejon-Agobe","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2020061010550795400_CIT0022","article-title":"Optimisation and standardisation of a multiplex immunoassay of diverse Plasmodium falciparum antigens to assess changes in malaria transmission using sero-epidemiology","volume":"4","author":"Lindsey Wu","year":"2019","journal-title":"Wellcome Open Research"},{"key":"2020061010550795400_CIT0023","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/IAI.03069-14","article-title":"Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection","volume":"83","author":"Obiero","year":"2015","journal-title":"Infect Immun"},{"key":"2020061010550795400_CIT0024","doi-asserted-by":"crossref","first-page":"E4438","DOI":"10.1073\/pnas.1501705112","article-title":"Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities","volume":"112","author":"Helb","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020061010550795400_CIT0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4161\/hv.6.1.10396","article-title":"Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria","volume":"6","author":"Hoffman","year":"2010","journal-title":"Hum Vaccin"},{"key":"2020061010550795400_CIT0026","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12916-017-0923-4","article-title":"Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial","volume":"15","author":"Walk","year":"2017","journal-title":"BMC Med"},{"key":"2020061010550795400_CIT0027","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpba.2010.08.009","article-title":"Measurement of lumefantrine and its metabolite in plasma by high performance liquid chromatography with ultraviolet detection","volume":"54","author":"Khalil","year":"2011","journal-title":"J Pharm Biomed Anal"},{"key":"2020061010550795400_CIT0028","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1016\/j.vaccine.2012.04.088","article-title":"A consultation on the optimization of controlled human malaria infection by mosquito bite for evaluation of candidate malaria vaccines","volume":"30","author":"Laurens","year":"2012","journal-title":"Vaccine"},{"key":"2020061010550795400_CIT0029","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0166-6851(01)00379-6","article-title":"Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR","volume":"118","author":"Hermsen","year":"2001","journal-title":"Mol Biochem Parasitol"},{"key":"2020061010550795400_CIT0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.molbiopara.2012.01.006","article-title":"Development of a quantitative flow cytometry-based assay to assess infection by Plasmodium falciparum sporozoites","volume":"183","author":"Kaushansky","year":"2012","journal-title":"Mol Biochem Parasitol"},{"key":"2020061010550795400_CIT0031","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00920-17","article-title":"The complement system contributes to functional antibody-mediated responses induced by immunization with Plasmodium falciparum malaria sporozoites","volume":"86","author":"Behet","year":"2018","journal-title":"Infect Immun"},{"key":"2020061010550795400_CIT0032","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4269\/ajtmh.15-0621","article-title":"Safety, immunogenicity, and protective efficacy of intradermal immunization with aseptic, purified, cryopreserved Plasmodium falciparum sporozoites in volunteers under chloroquine prophylaxis: a randomized controlled trial","volume":"94","author":"Bastiaens","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"2020061010550795400_CIT0033","doi-asserted-by":"crossref","first-page":"e0187059","DOI":"10.1371\/journal.pone.0187059","article-title":"Residual malaria transmission dynamics varies across The Gambia despite high coverage of control interventions","volume":"12","author":"Mwesigwa","year":"2017","journal-title":"PLoS One"},{"key":"2020061010550795400_CIT0034","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3389\/fmicb.2014.00686","article-title":"Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection","volume":"5","author":"Hodgson","year":"2014","journal-title":"Front Microbiol"},{"key":"2020061010550795400_CIT0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/oxfordjournals.bmb.a011689","article-title":"New insights into the epidemiology of malaria relevant for disease control","volume":"54","author":"Snow","year":"1998","journal-title":"Br Med Bull"},{"key":"2020061010550795400_CIT0036","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4269\/ajtmh.2012.11-0530","article-title":"Development of clinical immunity to malaria in highland areas of low and unstable transmission","volume":"87","author":"Rolfes","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"2020061010550795400_CIT0037","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1073\/pnas.0408725102","article-title":"Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure","volume":"102","author":"Drakeley","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020061010550795400_CIT0038","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1186\/s12879-017-2686-0","article-title":"Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with varying natural exposure","volume":"17","author":"Abdi","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2020061010550795400_CIT0039","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1475-2875-8-242","article-title":"What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity","volume":"8","author":"Kinyanjui","year":"2009","journal-title":"Malar J"},{"key":"2020061010550795400_CIT0040","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31549","article-title":"A randomized feasibility trial comparing four antimalarial drug regimens to induce Plasmodium falciparum gametocytemia in the controlled human malaria infection model","volume":"7","author":"Reuling","year":"2018","journal-title":"Elife"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz740\/31080284\/ciz740.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/70\/12\/2544\/33375441\/ciz740.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/70\/12\/2544\/33375441\/ciz740.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T00:39:57Z","timestamp":1664066397000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/70\/12\/2544\/5546068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,8,12]]},"published-print":{"date-parts":[[2020,6,10]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz740","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6,15]]},"published":{"date-parts":[[2019,8,12]]}}}